Zobrazeno 1 - 10
of 222
pro vyhledávání: '"Carl Harries"'
Autor:
Chinthaka B. Samaranayake, Ruth McNiven, Aleksander Kempny, Carl Harries, Laura C. Price, Michael Gatzoulis, Konstantinos Dimopoulos, Stephen J. Wort, Colm McCabe
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 17, Iss , Pp 100517- (2024)
Externí odkaz:
https://doaj.org/article/9fb05b5c49f04855bb88b2efc747438e
Autor:
Chinthaka B. Samaranayake, Ruth McNiven, Aleksander Kempny, Carl Harries, Laura C. Price, Michael Gatzoulis, Konstantinos Dimopoulos, Stephen J. Wort, Colm McCabe
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 7, Iss , Pp 100331- (2022)
Impaired ventilatory responses during exercise significantly contribute to breathlessness in patients with pulmonary arterial hypertension (PAH). Breathing reserve (BR) at peak exercise during cardiopulmonary exercise testing (CPET), a measure of the
Externí odkaz:
https://doaj.org/article/b1769b65a4984df2a8d685b8f79d9b49
Autor:
Iain Armstrong, Catherine Billings, David G. Kiely, Janelle Yorke, Carl Harries, Shaun Clayton, Wendy Gin-Sing
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-9 (2019)
Abstract Background Pulmonary Hypertension Association UK (PHA-UK) is the only charity in the UK especially for people affected by pulmonary hypertension (PH). To better understand the impact of PH on patients and carers beyond clinical symptoms, the
Externí odkaz:
https://doaj.org/article/6905db50b7bb4a1ab8792eccd327c5a3
Autor:
Timothy J. W. Dawes, Colm McCabe, Konstantinos Dimopoulos, Iain Stewart, Simon Bax, Carl Harries, Chinthaka B. Samaranayake, Aleksander Kempny, Philip L. Molyneaux, Samuel Seitler, Thomas Semple, Wei Li, Peter M. George, Vasileios Kouranos, Felix Chua, Elisabetta A. Renzoni, Maria Kokosi, Gisli Jenkins, Athol U. Wells, Stephen J. Wort, Laura C. Price
Publikováno v:
Respirology. 28:262-272
Background and Objective Pulmonary hypertension is a life-limiting complication of interstitial lung disease (ILD-PH). We investigated whether treatment with phosphodiesterase 5 inhibitors (PDE5i) in patients with ILD-PH was associated with improved
Autor:
Abigail Masding, Stephen D. Preston, Mark Toshner, Joseph Barnett, Carl Harries, Konstantinos Dimopoulos, Aleksander Kempny, Colm McCabe, David P. Jenkins, S. John Wort, Laura C. Price
Publikováno v:
Pulmonary Circulation, Vol 9 (2019)
A 36-year-old woman presented with recurrent pulmonary emboli (PE) despite oral anticoagulation. She was a type I diabetic with severe gastroparesis requiring insertion of multiple long-term peripherally inserted central catheters (PICC) over a 10-ye
Externí odkaz:
https://doaj.org/article/815a7924eae549a3a9a40c121450323b
Autor:
Rafael Alonso-Gonzalez, Laura C. Price, Michael A. Gatzoulis, Carl Harries, Heba Nashat, Aleksander Kempny, Natalie Dormand, Konstantinos Dimopoulos, SJ Wort
Publikováno v:
International Journal of Cardiology. 299:131-135
Background Pulmonary arterial hypertension (PAH), is a rare and progressive disease with a high morbidity and mortality. Prostanoid pulmonary vasodilators are the most effective treatment for idiopathic and connective tissue associated PAH. Nonethele
Autor:
Aleksander Kempny, Laura C. Price, Nicholas S Hopkinson, Colm McCabe, Yingmei Luo, Stuart Craig, Christopher Warren, James H. Hull, Konstantinos Dimopoulos, Karina Siewers, Chinthaka B Samaranayake, S. John Wort, Carl Harries, Michael A. Gatzoulis
Publikováno v:
Pulmonary hypertension.
Background: Breathlessness has significant impact on quality-of-life in patients with pulmonary arterial hypertension (PAH) yet few data assess ventilatory responses during day to day activities. In Eisenmenger syndrome (EIS), the additional impact o
Autor:
Alex Pitcher, Emma Weingart, Laura C. Price, Konstantinos Dimopoulos, Maria Kokosi, C. McCabe, Athol U. Wells, Chinthaka B Samaranayake, Carmel Bergbaum, Carl Harries, Aleksander Kempny, S. John Wort, Elizabeth Orchard, David Montani, Thomas Semple
Publikováno v:
The European respiratory journal. 57(6)
Pulmonary veno-occlusive disease (PVOD) is classified into idiopathic, heritable and associated with other conditions, most often connective tissue disease (CTD) and sarcoidosis. In patients with PVOD with a CTD, immunosuppressive therapies can impro
Autor:
Colm McCabe, Anna Reed, Susanna Price, Aimee Brame, Benjamin Garfield, Robin Condliffe, Thomas Pickworth, Luke Howard, David M. Alexander, Sean Gaine, TC Aw, Guillermo Martinez, S. Kemp, Benjamin E. Schreiber, Davina Wong, Denny Z. H. Levett, Chinthaka B Samaranayake, Carl Harries, Martin Johnson, Dolores Taboada, Bhashkar Mukherjee, David G. Kiely, Gerry Coghlan, Philip Marino, Stephen J. Wort, Laura C. Price, James L. Lordan, Konstantinos Dimopoulos, Stephane Ledot, Colin Church, Rachel J. Davies, Aleksander Kempny, Michael A. Gatzoulis, Andrew Curry
Publikováno v:
British journal of anaesthesia. 126(4)
Background The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hypertension (PAH) and chronic
Autor:
Luke Howard, Ben Garfield, Dolores Taboada, David G. Kiely, Tom Pickworth, Robin Condliffe, Colin Church, S. John Wort, James Lordan, Gerry Coghlan, Carl Harries, Sean Gaine, Aleksander Kempny, Stephane Ledot, Davina Wong, Andrew Curry, Rachel J. Davies, Laura C. Price, Philip Marino, Guillermo Martinez, Kostantinos Dimopoulos, Bhashkar Mukerjee, David M. Alexander, Martin Johnson, Nonni Reed, Susanna Price, Aimee Brame
Publikováno v:
Pulmonary hypertension.
Background: The risk of complications, including death, is markedly increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures. We performed a systematic literature review of available studies in patients wi